Prevalence and clinical associations of posttransplant fatty liver disease

Liver International

Volumn 27, Issue 1, 2007, Pages 76-80

  Lim, Lee Guan ^a   Cheng, Chee Leong ^a   Wee, Aileen ^a   Lim, Seng Gee ^a,b   Lee, Yin Mei ^a,b   Sutedja, Dede Selamat ^a   Da Costa, Maureen ^a   Prabhakaran, K ^a   Wai, Chun Tao ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Liver transplant; Metabolic syndrome; Non alcoholic fatty liver disease; Steatohepatitis

Indexed keywords

CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NONALCOHOLIC FATTY LIVER; PREVALENCE; STEATOSIS;

FATTY LIVER; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS;

EID: 33846419570     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01396.x     Document Type: Article

References (17)

1. Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-5.
2. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
3. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-95.
4. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129: 113-21.
5. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 1989; 20: 594-8.
6. Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
7. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology 2005; 42: 987-1000.
8. Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8: 861-79.
9. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transplant 2001; 7: 363-7.
10. Ong J, Younossi ZM, Reddy V, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transplant 2001; 7: 797-801.
11. Poordad F, Gish R, Wakil A, et al. De novo non-alcoholic fatty liver disease following orthotopic liver transplantation. Am J Transplant 2003; 3: 1413-7.
12. Powell EE, Jonsson JR, Clouston AD. Steatosis: Co-factor in other liver diseases. Hepatology 2005; 42: 5-13.
13. Wai CT, Lo SK, Lee KH, et al. Ten years of experience of liver transplantation in Singapore. Transplant Proc 2000; 32: 2139.
14. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
15. Kern WH, Heger AH, Payne JH, Dewind LT. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 1973; 96: 342-6.
16. Adams LA, Angulo P, Lindor KC. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
17. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transplant 2001; 7 (11 Suppl. 1): S13-21.